LK, W., DL, R., P, H., RC, S., K, O., L, S., . . . CA, E. (2021). Brief Report: Intranasal Ketamine in Adolescents and Young Adults with Autism Spectrum Disorder-Initial Results of a Randomized, Controlled, Crossover, Pilot Study. Journal of autism and developmental disorders, 51(4), 1392. https://doi.org/10.1007/s10803-020-04542-z
Chicago Style (17th ed.) CitationLK, Wink, Reisinger DL, Horn P, Shaffer RC, O'Brien K, Schmitt L, Dominick KR, Pedapati EV, and Erickson CA. "Brief Report: Intranasal Ketamine in Adolescents and Young Adults with Autism Spectrum Disorder-Initial Results of a Randomized, Controlled, Crossover, Pilot Study." Journal of Autism and Developmental Disorders 51, no. 4 (2021): 1392. https://doi.org/10.1007/s10803-020-04542-z.
MLA (9th ed.) CitationLK, Wink, et al. "Brief Report: Intranasal Ketamine in Adolescents and Young Adults with Autism Spectrum Disorder-Initial Results of a Randomized, Controlled, Crossover, Pilot Study." Journal of Autism and Developmental Disorders, vol. 51, no. 4, 2021, p. 1392, https://doi.org/10.1007/s10803-020-04542-z.